Effect of Morus alba on diabetes mellitus type 1

The effect of hydroalcoholic extract of Morus alba on glucose and lipid profiles in patient with diabetes mellitus type 1

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015030812438N11

Enrollment

Registered

2015-04-19

Start date

2015-04-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insulin-dependent diabetes mellitus. Insulin-dependent diabetes mellitus

Interventions

intervention:herbal capsule BID, for 3 months+ routine treatment.

Treatment - Drugs

intervention:herbal capsule BID, for 3 months+ routine treatment

Eligibility

Sex/Gender

All

Age

10 Years to 30 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients 10 to 30 years who have insulin-dependent diabetes disease and HbA1c in his with more than 7 percent. Exclusion criteria: LDL cholesterol and triglycerides less than 160 and less than 200 respectively. Liver disease, kidney disease, not use of lipid-lowering drugs.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
HbA1C. Timepoint: months 0,2,4,6. Method of measurement: percent of glycosylated hemoglobin.;Fasting plasma glucose. Timepoint: months 0,2,4,6. Method of measurement: Enzymatic.;Tg. Timepoint: months 0,2,4,6. Method of measurement: blood sample.;Cholesterol. Timepoint: months 0,2,4,6. Method of measurement: blood sample.;LDL. Timepoint: months 0,2,4,6. Method of measurement: blood sample.;HDL. Timepoint: months 0,2,4,6. Method of measurement: blood sample.;CRP. Timepoint: months 0,2,4,6. Method of measurement: blood sample.;ALT,AST. Timepoint: months 0,2,4,6. Method of measurement: blood sample.	—

Measure

Time frame

HbA1C. Timepoint: months 0,2,4,6. Method of measurement: percent of glycosylated hemoglobin.;Fasting plasma glucose. Timepoint: months 0,2,4,6. Method of measurement: Enzymatic.;Tg. Timepoint: months 0,2,4,6. Method of measurement: blood sample.;Cholesterol. Timepoint: months 0,2,4,6. Method of measurement: blood sample.;LDL. Timepoint: months 0,2,4,6. Method of measurement: blood sample.;HDL. Timepoint: months 0,2,4,6. Method of measurement: blood sample.;CRP. Timepoint: months 0,2,4,6. Method of measurement: blood sample.;ALT,AST. Timepoint: months 0,2,4,6. Method of measurement: blood sample.

—

Secondary

Measure	Time frame
Taking insulin. Timepoint: months 0,2,4,6. Method of measurement: questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.M.Taghizadeh

Kashan University of Medical Sciences

taghizadeh_m@kaums.ac.ir+98 31 5554 0021

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026